STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Schedule 13G: ADAR1 Discloses 3.375M Shares of Prothena (6.3%)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

ADAR1 Capital Management and related parties reported beneficial ownership of 3,375,009 ordinary shares of Prothena Corporation plc, representing 6.3% of the outstanding common stock as of June 30, 2025. The filing breaks the position into 2,892,995 shares held by ADAR1 Partners, LP and 482,014 shares held by Spearhead Insurance Solutions IDF, LLC. ADAR1 Capital Management, LLC reports shared voting and dispositive power over the full 3,375,009-share position. The filing cites 53,826,982 ordinary shares outstanding based on the Issuer's 10-Q filed August 4, 2025. The Schedule 13G is signed by Daniel Schneeberger on behalf of the reporting entities on August 14, 2025.

Positive

  • Material stake disclosed: Reports beneficial ownership of 3,375,009 shares (6.3%), which is a significant, reportable position.
  • Transparency among affiliates: Filing details allocation between ADAR1 Partners, LP (2,892,995 shares) and Spearhead Insurance Solutions IDF, LLC (482,014 shares) and includes a Joint Filing Agreement.
  • Clear classification: Filed on Schedule 13G with a certification stating holdings are in the ordinary course of business and not intended to influence control.

Negative

  • None.

Insights

TL;DR: ADAR1 group disclosed a passive 6.3% stake (3.375M shares) in PRTA, filed on Schedule 13G, indicating non-control intent.

The filing reports a combined beneficial ownership of 3,375,009 ordinary shares, representing 6.3% of Prothena's 53,826,982 shares outstanding. The cover page allocation shows 2,892,995 shares held by ADAR1 Partners, LP and 482,014 shares held by Spearhead Insurance Solutions IDF, LLC. ADAR1 Capital Management, LLC states shared voting and dispositive power; the Schedule 13G classification and the certification language indicate the position is held in the ordinary course of business and not for control. For investors, this disclosure provides clarity on a meaningful passive holder but contains no operational or financial projections.

TL;DR: This is a standard Schedule 13G passive ownership disclosure showing shared control among affiliated entities and an individual.

The document identifies three reporting persons: ADAR1 Capital Management, LLC (investment adviser), ADAR1 Capital Management GP, LLC (general partner), and Daniel Schneeberger (manager/individual). The filing attributes shared voting and dispositive power over the reported shares to the adviser and related entities. The Schedule 13G classification and the signed certification assert the holdings were not acquired to influence control. The exhibit list includes a Joint Filing Agreement, consistent with coordinated reporting among affiliates.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Includes (i) 2,892,995 ordinary shares, par value $0.01 per share ("Ordinary Shares") held by ADAR1 Partners, LP and (ii) 482,014 ordinary shares held by Spearhead Insurance Solutions IDF, LLC as of June 30, 2025. As the investment manager of ADAR1 Partners, LP and as the sub-advisor of Spearhead Insurance Solutions IDF, LLC, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC. Based on 53,826,982 ordinary shares of Prothena Corporation Public Limited Company (the "Issuer") outstanding as of June 30, 2025 reported in the Issuer's 10-Q, filed with the SEC on August 4, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 2,892,995 ordinary shares, $0.01 per share ("Ordinary Shares") held by ADAR1 Partners, LP as of June 30, 2025. As the general partner of ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP. Based on 53,826,982 ordinary shares of Prothena Corporation Public Limited Company (the "Issuer") outstanding as of June 30, 2025 reported in the Issuer's 10-Q, filed with the SEC on August 4, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes (i) 2,892,995 ordinary shares, par value $0.01 per share ("Ordinary Shares") held by ADAR1 Partners, LP and (ii) 482,014 ordinary shares held by Spearhead Insurance Solutions IDF, LLC as of June 30, 2025. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC. Based on 53,826,982 ordinary shares of Prothena Corporation Public Limited Company (the "Issuer") outstanding as of June 30, 2025 reported in the Issuer's 10-Q, filed with the SEC on August 4, 2025.


SCHEDULE 13G



ADAR1 Capital Management, LLC
Signature:/s/ Daniel Schneeberger
Name/Title:Daniel Schneeberger, Manager
Date:08/14/2025
ADAR1 Capital Management GP, LLC
Signature:/s/ Daniel Schneeberger
Name/Title:Daniel Schneeberger, Manager
Date:08/14/2025
Daniel Schneeberger
Signature:/s/ Daniel Schneeberger
Name/Title:Daniel Schneeberger, in his individual capacity
Date:08/14/2025
Exhibit Information

Exhibit A: Joint Filing Agreement

FAQ

What stake in Prothena (PRTA) does ADAR1 report?

The reporting persons disclose beneficial ownership of 3,375,009 ordinary shares, equal to 6.3% of outstanding shares as of June 30, 2025.

How are the 3,375,009 shares allocated among ADAR1-related entities?

2,892,995 shares are held by ADAR1 Partners, LP and 482,014 shares are held by Spearhead Insurance Solutions IDF, LLC.

Does the filing indicate ADAR1 seeks control of Prothena?

No. The Schedule 13G certification states the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control.

What voting and dispositive power is reported?

ADAR1 Capital Management, LLC reports 0 sole voting/dispositive power and 3,375,009 shared voting and shared dispositive power over the shares.

What outstanding share count is the percent ownership based on?

The percent is calculated using 53,826,982 ordinary shares outstanding as reported in the Issuer's 10-Q filed August 4, 2025.
Prothena

NASDAQ:PRTA

PRTA Rankings

PRTA Latest News

PRTA Latest SEC Filings

PRTA Stock Data

600.74M
43.39M
18.66%
79.67%
7.53%
Biotechnology
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2